4577Background: ChRCC constitutes 5-10% of all RCC cases, and is generally associated with better prognosis including benefit from approved targeted agents (Armstrong, Lancet Onc, 2016). Presence o... Click to show full abstract
4577Background: ChRCC constitutes 5-10% of all RCC cases, and is generally associated with better prognosis including benefit from approved targeted agents (Armstrong, Lancet Onc, 2016). Presence o...
               
Click one of the above tabs to view related content.